Lab Leaks are Far More Common Than We’re Told
Children's Health Defense highlighted a recent biosafety breach at NIH's Rocky Mountain Laboratories (RML) in Hamilton, Montana. In November 2025, a researcher potentially exposed themselves to Crimean-Congo Haemorrhagic Fever Virus (CCHF), a tick-borne pathogen with up to 40% fatality rate, causing severe bleeding, organ failure, and no widely available treatments, when their personal protective equipment (PPE) was breached. NIH confirmed the incident but emphasised no actual infection occurred, no risk to the public or other staff, and the worker was monitored.
This isn't an isolated "oops." It is symptomatic of a broader, underreported reality: laboratory accidents involving dangerous pathogens happen with disturbing regularity, even in high-containment facilities.
RML is one of the U.S.'s premier BSL-3/BSL-4 facilities, researching tick-borne diseases, Ebola, plague, and other high-risk agents. The CCHF incident triggered emergency protocols but stayed contained. Critics, including RFK Jr.-aligned voices at CHD, use it to underscore ongoing risks from gain-of-function-style research and dual-use pathogen work. NIH's track record includes past issues at the same lab (e.g., escaped infected mice in prior years).
Lab Leaks: Not Rare, Just UnderreportedHistorical data shows lab-acquired infections (LAIs) and accidental pathogen escapes (APELs) are surprisingly common:
A 2024 scoping review found 309 laboratory-acquired infections across 94 reports (2000–2021) involving 51 pathogens, plus 16 documented escapes from biocontainment. These are almost certainly undercounts due to poor mandatory reporting.
Earlier compilations (1979–2015) logged over 2,200 LAIs and dozens of deaths from publicly reported cases alone.
Notable historical escapes include: 1977 H1N1 "Russian flu" (likely a lab strain), multiple SARS-CoV-1 escapes from Asian labs in 2003–2004, the 1979 Sverdlovsk anthrax release (68+ deaths), and the 2007 UK Foot-and-Mouth outbreak from a leaky pipe.
Even select agent labs (handling the most dangerous pathogens) report dozens of incidents annually in the U.S. Needles sticks, PPE failures, spills, and procedural errors dominate. Human factors, fatigue, complacency, training gaps, persist despite stringent protocols.
Modern labs study increasingly transmissible or virulent pathogens. Gain-of-function research (enhancing transmissibility or virulence to study threats) amplifies both the stakes and the accident probability. A single escape of a novel or enhanced pathogen could spark the next pandemic, exactly the debate that still rages over COVID-19's origins.
Defenders argue BSL-4 labs have strong safety records overall, with redundant systems and no major community outbreaks from U.S. facilities. Yet the pattern is clear: accidents occur, transparency is inconsistent, and incentives favour downplaying risks to protect funding and careers.
The Montana incident, minor in outcome, highlights systemic vulnerabilities. As global labs proliferate (including in nations with weaker oversight), the cumulative risk grows. Calls for stricter oversight, pauses on certain high-risk experiments, better real-time reporting, and independent audits are not "anti-science." They are pro-accountability.
Pretending leaks are vanishingly rare is wishful thinking. The data, from Montana to historical tallies, shows otherwise. Robust biosafety, humility about human error, and prioritising truly essential research over prestige projects would reduce risks. Lab leaks aren't inevitable, but they are common enough that complacency is dangerous. The next breach might not stay contained.
